Signe Friesland

Neck
Stockholm, AB, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 53 publications

Radiotherapy with or without concurrent cetuximab in HPV-positive oropharyngeal squamous cell carcinoma - A pooled analysis from two ARTSCAN trials.

Radiotherapy with or without concurrent cetuximab in HPV-positive oropharyngeal squamous cell carcinoma - A pooled analysis from two ARTSCAN trials.

Journal: Clinical and translational radiation oncology

Published: March 31, 2026

Acute and long-term toxicity profiles and final oncologic outcomes in the phase III ARTFORCE trial.

Acute and long-term toxicity profiles and final oncologic outcomes in the phase III ARTFORCE trial.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: January 23, 2026

FOCU.SE trial: a nationwide Swedish drug repurposing protocol and research framework.

FOCU.SE trial: a nationwide Swedish drug repurposing protocol and research framework.

Journal: Acta oncologica (Stockholm, Sweden)

Published: January 23, 2026

Estimation of accumulated dose to organs at risk in head and neck cancer patients treated with scheduled replanning and dose painting in the ARTFORCE trial.

Estimation of accumulated dose to organs at risk in head and neck cancer patients treated with scheduled replanning and dose painting in the ARTFORCE trial.

Journal: Physics and imaging in radiation oncology

Published: November 28, 2025

MEK inhibition in adult patients with pilocytic astrocytomas.

MEK inhibition in adult patients with pilocytic astrocytomas.

Journal: NPJ precision oncology

Published: October 11, 2025

Prognostic impact of HLA class I immunohistochemistry staining intensity with regard to the risk of recurrence of adenoid cystic carcinoma.

Prognostic impact of HLA class I immunohistochemistry staining intensity with regard to the risk of recurrence of adenoid cystic carcinoma.

Journal: Molecular and clinical oncology

Published: October 06, 2025

Circulating cell free HPVDNA in HPV positive head and neck cancer reveals fast responders and early peakers during treatment.

Circulating cell free HPVDNA in HPV positive head and neck cancer reveals fast responders and early peakers during treatment.

Journal: Scientific reports

Published: August 18, 2025

Validated prediction of xerostomia in a real-world population: a step toward model-guided radiotherapy.

Validated prediction of xerostomia in a real-world population: a step toward model-guided radiotherapy.

Journal: Acta oncologica (Stockholm, Sweden)

Published: May 01, 2025

Comparing adaptive and dose redistributed radiotherapy to conventional radiotherapy in head and neck cancer - Quality of life results from the phase III ARTFORCE trial.

Comparing adaptive and dose redistributed radiotherapy to conventional radiotherapy in head and neck cancer - Quality of life results from the phase III ARTFORCE trial.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: April 22, 2025

Chemoradiation therapy With Cisplatin Versus Cetuximab in Patients With Locoregionally Advanced Head and Neck Squamous Cell Cancer-Mature Results of the ARTSCAN III Trial.

Chemoradiation therapy With Cisplatin Versus Cetuximab in Patients With Locoregionally Advanced Head and Neck Squamous Cell Cancer-Mature Results of the ARTSCAN III Trial.

Journal: International journal of radiation oncology, biology, physics

Published: January 08, 2025

Protocol compliance in a multicentric phase III trial investigating scheduled adaptive radiotherapy and dose painting in head and neck cancer.

Protocol compliance in a multicentric phase III trial investigating scheduled adaptive radiotherapy and dose painting in head and neck cancer.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: August 09, 2024

"High-risk" tumors of the lip treated with external beam radiotherapy and high-dose-rate brachytherapy: Long-term outcome.

"High-risk" tumors of the lip treated with external beam radiotherapy and high-dose-rate brachytherapy: Long-term outcome.

Journal: Head & neck

Published: May 23, 2024

Showing 1-12 of 53

Last Updated: 09/26/2026